V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012292 | 330004342 | 1.85 | null | Palliative (P) | 2016-11-06 | 2016-11-27 | Rituximab | N | Y | 330011479 | RITUXIMAB |
| 330012293 | 330004345 | null | 71.6 | Curative (C) | null | 2015-07-21 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 330011480 | RITUXIMAB |
| 330012294 | 330004348 | 1.73 | 90 | Curative (C) | null | 2014-05-11 | Rituximab | N | N | 330011497 | RITUXIMAB |
| 330012295 | 330008375 | 1.69 | 95 | Neo-adjuvant (N) | 2017-07-02 | 2017-09-24 | CARBOPLATIN | N | N | 330011513 | CARBOPLATIN |
| 330012296 | 330004356 | 1.72 | null | Curative (C) | 2014-11-06 | 2014-11-10 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330011517 | MAP |
| 330012297 | 330008378 | 1.32 | 82.6 | Palliative (P) | 2014-03-30 | 2014-04-04 | Etoposide + Ifosfamide (5 days) | N | N | 330011529 | ETOPOSIDE + IFOSFAMIDE |
| 330012298 | 330004366 | 1.73 | 66 | Palliative (P) | 2018-12-28 | 2019-01-13 | Methotrexate High Dose (3g/m2) | N | N | 330011598 | METHOTREXATE HIGH DOSE |
| 330012299 | 330004369 | 1.7 | 72.4 | null | 2018-09-26 | 2018-11-11 | Paclitaxel 7 day | N | Y | 330011603 | PACLITAXEL |
| 330012300 | 330013038 | 1.74 | null | Curative (C) | 2014-12-05 | 2015-06-06 | ALL UKALL2011 Del Int A Pt1 (PAsp) | N | N | 330011654 | UKALL2011 |
| 330012301 | 330004381 | 1.68 | 17.5 | Palliative (P) | null | 2015-02-05 | Paclitaxel (2 or 3 weekly) | Y | null | 330011679 | PACLITAXEL |
| 330012302 | 330004382 | 1.75 | 62.9 | Curative (C) | 2014-09-28 | 2014-09-28 | ALL UKALL2011 Ind A Std Dex (PAsp) | N | Y | 330011685 | UKALL2011 |
| 330012303 | 330008395 | 1.59 | null | Palliative (P) | 2017-07-23 | 2017-08-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330011757 | CARBOPLATIN + PACLITAXEL |
| 330012304 | 330004406 | 1.7 | null | Curative (C) | 2014-03-05 | 2014-07-16 | EURAMOS TRIAL | Y | N | 330011786 | EURAMOS TRIAL |
| 330012305 | 330008401 | 1.7 | null | Palliative (P) | 2015-01-31 | 2015-01-31 | Cetuximab + Radiotherapy Load | N | N | 330011787 | CETUXIMAB + RT |
| 330012306 | 330004415 | 1.66 | 55.2 | Neo-adjuvant (N) | 2016-10-30 | 2017-03-14 | CARBOPLATIN + RT | N | N | 330011813 | CARBOPLATIN + RT |
| 330012307 | 330004420 | 1.75 | null | Palliative (P) | 2017-01-03 | 2017-03-01 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011825 | CARBOPLATIN + PACLITAXEL |
| 330012308 | 330004423 | null | 79.7 | Palliative (P) | null | 2016-01-03 | CARBOPLATIN + ETOPOSIDE | N | null | 330011856 | CARBOPLATIN + ETOPOSIDE |
| 330012309 | 330013249 | 1.62 | 57.35 | Curative (C) | 2017-10-05 | 2017-10-07 | Paclitaxel 7 day | N | N | 330011940 | PACLITAXEL |
| 330012310 | 330004439 | 1.57 | 43.8 | Not known (9) | 2014-09-06 | 2014-09-06 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 330011961 | PACLITAXEL |
| 330012311 | 330004442 | 1.59 | 72.9 | Curative (C) | 2014-05-30 | 2014-05-30 | BENDAMUSTINE + RITUXIMAB | N | N | 330011962 | BENDAMUSTINE + RITUXIMAB |
| 330012312 | 330004444 | 0 | 67.9 | Palliative (P) | 2018-09-28 | 2018-10-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330011964 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012313 | 330004447 | 1.67 | 8.3 | Curative (C) | null | 2018-12-16 | ALL UKALL2011 Maintenance A1 | N | N | 330011981 | UKALL2011 |
| 330012314 | 330010569 | 1.73 | 18 | Curative (C) | 2013-05-18 | 2013-05-20 | CARBOPLATIN + RT | N | Y | 330012034 | CARBOPLATIN + RT |
| 330012315 | 330004489 | 1.65 | 54.1 | Palliative (P) | 2016-05-11 | 2017-02-04 | VAI (Ifos 3g/m2) | 02 | N | 330012203 | VAI |
| 330012316 | 330004504 | 1.7 | 15.2 | Palliative (P) | 2019-11-22 | 2019-11-22 | CARBOPLATIN + PACLITAXEL | 02 | N | 330012272 | CARBOPLATIN + PACLITAXEL |
| 330012317 | 330004510 | 1.54 | 61.9 | Curative (C) | 2013-07-24 | 2013-12-18 | CARBOPLATIN + RT | null | N | 330012287 | CARBOPLATIN + RT |
| 330012318 | 330004516 | 1.59 | 63 | Neo-adjuvant (N) | 2014-01-21 | 2014-08-02 | Carboplatin + Etoposide IV 3 day | 02 | N | 330012305 | CARBOPLATIN + ETOPOSIDE |
| 330012319 | 330004520 | 1.48 | 12.7 | Palliative (P) | 2015-11-21 | 2015-11-26 | Paclitaxel (2 or 3 weekly) | N | N | 330012324 | PACLITAXEL |
| 330012320 | 330008468 | 1.75 | null | Curative (C) | 2014-01-29 | 2014-04-05 | Cetuximab + Radiotherapy Load | 2 | N | 330012352 | CETUXIMAB + RT |
| 330012321 | 330004537 | 1.02 | 71.6 | Palliative (P) | null | 2018-12-23 | EURAMOS TRIAL | null | null | 330012373 | EURAMOS TRIAL |
| 330012322 | 330008473 | 1.86 | 53.4 | Palliative (P) | 2017-01-22 | 2017-06-10 | Cetuximab + Radiotherapy Maint | N | N | 330012378 | CETUXIMAB + RT |
| 330012323 | 330008474 | 1.72 | 46.5 | Curative (C) | 2018-03-17 | 2018-03-17 | EURAMOS TRIAL | 02 | N | 330012379 | EURAMOS TRIAL |
| 330012324 | 330008476 | 0 | 84 | null | 2014-11-30 | 2015-02-01 | CARBOPLATIN + RT | 2 | N | 330012382 | CARBOPLATIN + RT |
| 330012325 | 330004548 | 1.61 | 11.3 | Palliative (P) | 2017-12-27 | 2017-12-27 | Carbo F | 02 | N | 330012411 | CARBO + FLUOROURACIL |
| 330012326 | 330004556 | null | 64 | Curative (C) | 2019-01-17 | 2019-01-17 | Carboplatin + Etoposide iv&po | N | Y | 330012450 | CARBOPLATIN + ETOPOSIDE |
| 330012327 | 330004579 | 1.75 | 53.2 | null | 2018-04-23 | 2018-07-18 | Cetuximab + Radiotherapy Load | N | N | 330012557 | CETUXIMAB + RT |
| 330012328 | 330004588 | 1.78 | 103.5 | Palliative (P) | 2014-09-18 | 2018-02-05 | EURAMOS TRIAL | N | N | 330012594 | EURAMOS TRIAL |
| 330012329 | 330008504 | 1.32 | null | Disease modification (D) | 2014-05-16 | 2014-05-16 | CARBOPLATIN + RT | 02 | N | 330012604 | CARBOPLATIN + RT |
| 330012331 | 330004595 | 1.64 | 8.3 | Palliative (P) | 2015-01-29 | 2015-04-15 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 330012615 | CARBO + FLUOROURACIL |
| 330012332 | 330004597 | 1.67 | 69.9 | Palliative (P) | 2017-06-02 | 2017-07-02 | Carboplatin + Etoposide IV 3 day | 02 | null | 330012621 | CARBOPLATIN + ETOPOSIDE |
| 330012333 | 330008510 | null | 67.7 | Curative (C) | 2019-04-23 | 2019-05-21 | CARBOPLATIN + ETOPOSIDE | null | null | 330012634 | CARBOPLATIN + ETOPOSIDE |
| 330012334 | 330004627 | 1.77 | 0 | Curative (C) | null | 2014-11-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330012730 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012335 | 330004635 | null | 59.2 | Palliative (P) | 2015-07-09 | 2015-11-01 | Paclitaxel (2 or 3 weekly) | N | N | 330012785 | PACLITAXEL |
| 330012336 | 330008525 | 1.63 | 14.8 | Palliative (P) | 2014-12-27 | 2015-01-28 | Carboplatin + Etoposide IV 3 day | N | Y | 330012805 | CARBOPLATIN + ETOPOSIDE |
| 330012337 | 330013047 | 1.85 | 72.2 | Palliative (P) | null | 2017-05-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330012860 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012338 | 330008543 | 1.7 | 43.95 | Palliative (P) | 2017-08-03 | 2017-11-04 | Carboplatin + Paclitaxel (3 weekly) | 02 | Y | 330012935 | CARBOPLATIN + PACLITAXEL |
| 330012339 | 330004675 | 1.75 | 19.7 | Palliative (P) | 2017-04-22 | 2017-04-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330012987 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330012340 | 330011795 | 1.58 | 14.5 | Curative (C) | 2017-09-23 | 2017-09-23 | ALL UKALL2011 Ind B Sht Dex (PAsp) | null | N | 330012994 | UKALL2011 |
| 330012341 | 330004680 | 1.8 | 71.6 | Curative (C) | 2017-06-17 | 2017-06-24 | CARBOPLATIN + RT | N | N | 330013003 | CARBOPLATIN + RT |
| 330012342 | 330004683 | 1.78 | 53.1 | Palliative (P) | 2018-11-06 | 2018-11-15 | EURAMOS TRIAL | N | N | 330013032 | EURAMOS TRIAL |